Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens

Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; pp. viii576 - viii577
Main Authors: George, S., Heinrich, M., Chi, P., Razak, A., von Mehren, M., Gordon, M., Ganjoo, K.N., Somaiah, N., Trent, J.C., Rodon Ahnert, J., Wolf, J., Ruiz-Soto, R., Rosen, O., Janku, F.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy299.002